ML LifeSciences

Established in 2006, ML LifeSciences routinely manufactures custom proprietary as well as common sterile solutions for use within four vertical markets: • sterility release confirmation testing • cell culture media in tissue biopsy transport • specialty molecular diagnostic and laboratory applications • veterinary medicine Routinely manufactured products include: • Liquid QC media, i.e. Tryptic Soy broth (TSB); Fluid Thioglycollate Media (FTM); Fluid A, Fluid D and Fluid K • Cell culture media such as, but not limited to: Phosphate Buffered Saline RPMI 1640 DPBS McCoy formulations Eagle media MEM solutions • Proprietary molecular diagnostic formulations • Proprietary cellular preservation formulations • Proprietary veterinary formulations Commonly utilized sterile packaging capabilities include • Flexible solution containers (bags) in volumes from 50 ml to 20 L • Vial, tube and bottle filling, stoppering, crimp/cap (microliters to liters) • Aseptic fill including non-injectable syringes • Dry chemical reagent container fill By providing products to customer specifications, ML LifeSciences reduces costs, limiting waste and increasing convenience.

• Employees 3
• Founded 2006
• Annual Revenue $10000000